CE

MKT CAP:$7B

Celanese Corporation

Market Cap

$7B

Basic Materials·Chemicals·🇺🇸 United States·NYSE

Materials·Chemicals·🇺🇸·NYSE

Stock Price

$65.77+$23.61 (+56.00%)

Apr 22, 2026

Company Details

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Ace...

CEO

Scott A. Richardson

IPO Date

Jan 21, 2005

Website

www.celanese.com

Key Metrics TTM

Revenue

$10.1B

-0.4% YoY

Net Income

-$2.2B

EPS (Diluted)

-$20.10

Free Cash Flow

$1.0B

Revenue / Share

$92.36

Gross Margin

22.6%

Operating Margin

-16.1%

Net Margin

-21.7%

FCF Margin

10.0%

P/S

0.7x

P/E

—

Earnings Reports

Q4 2025

May 5, 2026

PENDING

Q3 2025

Nov 7, 2025

$2.4BEPS -$12.39

Q4 2024

Feb 21, 2025

$2.4BEPS -$17.50

Q1 2024

May 10, 2024

$2.6BEPS $1.10

FY 2023

Feb 23, 2024

$10.9B+13.1%EPS $17.92

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 18	$1.8B	$516M	$374M
Q1 19	$1.7B	$453M	$320M
Q2 19	$1.6B	$423M	$186M
Q4 20	$1.6B	$376M	$203M
Q1 21	$1.8B	$485M	$326M
Q2 21	$2.2B	$761M	$567M
Q3 21	$2.3B	$715M	$536M
Q4 21	$2.3B	$721M	$517M
Q1 22	$2.5B	$745M	$531M
Q2 22	$2.5B	$705M	$483M
Q4 22	$2.3B	$384M	$56M
Q2 23	$2.8B	$686M	$335M
Q3 23	$2.7B	$673M	$842M
Q1 24	$2.6B	$554M	$210M
Q4 24	$2.4B	$539M	-$1.4B
Q3 25	$2.4B	$521M	-$1.3B

Valuation

Quarter	P/S	P/E
Q3 18	2.3x	12.4x
Q1 19	1.8x	9.9x
Q2 19	2.0x	10.4x
Q4 20	2.2x	6.2x
Q1 21	2.6x	7.4x
Q2 21	2.3x	6.6x
Q3 21	2.2x	6.1x
Q4 21	2.1x	9.6x
Q1 22	1.7x	7.5x
Q2 22	1.4x	6.9x
Q4 22	1.3x	5.7x
Q2 23	1.3x	6.6x
Q3 23	1.3x	5.6x
Q1 24	1.8x	9.1x
Q4 24	0.7x	—
Q3 25	0.4x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 18	$467M	$388M
Q1 19	$307M	$228M
Q2 19	$424M	$359M
Q4 20	$274M	$189M
Q1 21	$116M	$24M
Q2 21	$427M	$317M
Q3 21	$630M	$528M
Q4 21	$584M	$421M
Q1 22	$316M	$179M
Q2 22	$495M	$371M
Q4 22	$541M	$398M
Q2 23	$762M	$617M
Q3 23	$403M	$272M
Q1 24	$101M	-$36M
Q4 24	$494M	$389M
Q3 25	$447M	$383M

Capital Expenditures

Quarter	CapEx
Q3 18	$79M
Q1 19	$79M
Q2 19	$65M
Q4 20	$85M
Q1 21	$92M
Q2 21	$110M
Q3 21	$102M
Q4 21	$163M
Q1 22	$137M
Q2 22	$124M
Q4 22	$143M
Q2 23	$145M
Q3 23	$131M
Q1 24	$137M
Q4 24	$105M
Q3 25	$64M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 19	+27.5%	+26.9%
Q2 19	-0.1%	+2.2%
Q4 20	-13.7%	-6.6%
Q1 21	+1.5%	+5.4%
Q2 21	+30.3%	+19.3%
Q3 21	+42.3%	+23.0%
Q4 21	+43.0%	+26.7%
Q1 22	+41.2%	+36.3%
Q2 22	+13.1%	+22.8%
Q4 22	+3.6%	+32.5%
Q2 23	+22.9%	+39.9%
Q3 23	+7.3%	-6.3%
Q1 24	+5.0%	+19.9%
Q4 24	+0.9%	+64.7%
Q3 25	-13.5%	+50.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 18	$14M	0.8%
Q1 19	$14M	0.8%
Q2 19	$13M	0.8%
Q4 20	$11M	0.7%
Q1 21	$12M	0.7%
Q2 21	$42M	1.9%
Q3 21	$22M	1.0%
Q4 21	$19M	0.8%
Q1 22	$15M	0.6%
Q2 22	$16M	0.6%
Q4 22	$13M	0.6%
Q2 23	$18M	0.6%
Q3 23	$4M	0.1%
Q1 24	$10M	0.4%
Q4 24	$9M	0.4%
Q3 25	$7M	0.3%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q3 18	$18M	—	$129M
Q1 19	$16M	—	$120M
Q2 19	$17M	—	$118M
Q4 20	$20M	—	$137M
Q1 21	$20M	—	$137M
Q2 21	$22M	—	$161M
Q3 21	$21M	—	$165M
Q4 21	$23M	—	$170M
Q1 22	$24M	—	$174M
Q2 22	$26M	—	$197M
Q4 22	$37M	—	$269M
Q2 23	$40M	$276M	—
Q3 23	$32M	$244M	—
Q1 24	$34M	—	$265M
Q4 24	$31M	—	$262M
Q3 25	$31M	—	$231M

Revenue Segments

Quarter	Acetate Tow	Acetyl Intermediates	Engineered Materials	Industrial Specialties	Acetyl Chain
Q3 18	$158M	$698M	$642M	$273M	—
Q1 19	$166M	—	$663M	—	$858M
Q2 19	$164M	—	$593M	—	$835M
Q4 20	$134M	—	$572M	—	$885M
Q1 21	$119M	—	$645M	—	$1.0B
Q2 21	$138M	—	$682M	—	$1.4B
Q3 21	$128M	—	$684M	—	$1.5B
Q4 21	$129M	—	$707M	—	$1.4B
Q1 22	$125M	—	$910M	—	$1.5B
Q2 22	$119M	—	$948M	—	$1.4B
Q2 23	—	—	$1.6B	—	$1.2B
Q3 23	—	—	$1.5B	—	$1.2B
Q1 24	—	—	$1.4B	—	$1.2B
Q4 24	—	—	$1.3B	—	$1.1B
Q3 25	—	—	$1.4B	—	$1.1B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$605M	$9M	$614M
Q2 22	$783M	$7M	$790M
Q3 22	$9.7B	$0	$9.7B
Q4 22	$1.5B	$0	$1.5B
Q1 23	$1.2B	$0	$1.2B
Q2 23	$1.3B	$0	$1.3B
Q3 23	$1.4B	$0	$1.4B
Q4 23	$1.8B	$0	$1.8B
Q1 24	$1.5B	$0	$1.5B
Q2 24	$1.2B	$0	$1.2B
Q3 24	$813M	$0	$813M
Q4 24	$962M	$0	$962M
Q1 25	$951M	$0	$951M
Q2 25	$1.2B	$0	$1.2B
Q3 25	$1.4B	$0	$1.4B
Q4 25	$1.3B	$0	$1.3B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 18	135M	-0.6%	—
Q1 19	128M	-5.4%	-11.3%
Q2 19	126M	-1.8%	-7.7%
Q4 20	116M	-7.6%	-14.7%
Q1 21	114M	-2.0%	-15.8%
Q2 21	113M	-1.1%	-12.1%
Q3 21	111M	-1.5%	-11.8%
Q4 21	109M	-1.5%	-5.9%
Q1 22	109M	-0.4%	-4.5%
Q2 22	109M	+0.2%	-3.2%
Q4 22	109M	+0.1%	-1.7%
Q2 23	109M	+0.1%	-0.1%
Q3 23	109M	+0.1%	+0.5%
Q1 24	110M	+0.1%	+0.4%
Q4 24	109M	-0.1%	+0.2%
Q3 25	110M	+0.2%	+0.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 18	$233.3K	8K
Q1 19	$219.5K	8K
Q2 19	$207.2K	8K
Q4 20	$207.8K	8K
Q1 21	$234.8K	8K
Q2 21	$287.0K	8K
Q3 21	$295.9K	8K
Q4 21	$266.7K	9K
Q1 22	$297.6K	9K
Q2 22	$291.5K	9K
Q4 22	$177.0K	13K
Q2 23	$210.7K	13K
Q3 23	$205.3K	13K
Q1 24	$210.4K	12K
Q4 24	$194.9K	12K
Q3 25	$198.9K	12K

Revenue / Employee